| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 2/6 |
HYDI Stock Overview
Hydromer, Inc. invents, develops, patents, licenses, manufactures, and sells hydrophilic polymer-based products and services in the United States and internationally.
Hydromer Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.32 |
| 52 Week High | US$0.93 |
| 52 Week Low | US$0.24 |
| Beta | 0 |
| 1 Month Change | 33.33% |
| 3 Month Change | -8.57% |
| 1 Year Change | -58.97% |
| 3 Year Change | -70.91% |
| 5 Year Change | -50.77% |
| Change since IPO | -13.51% |
Recent News & Updates
Shareholder Returns
| HYDI | US Chemicals | US Market | |
|---|---|---|---|
| 7D | 6.6% | 0.2% | -0.6% |
| 1Y | -59.0% | -12.5% | -21.7% |
Return vs Industry: HYDI underperformed the US Chemicals industry which returned -11.1% over the past year.
Return vs Market: HYDI underperformed the US Market which returned -20.8% over the past year.
Price Volatility
| HYDI volatility | |
|---|---|
| HYDI Average Weekly Movement | n/a |
| Chemicals Industry Average Movement | 6.8% |
| Market Average Movement | 8.0% |
| 10% most volatile stocks in US Market | 16.8% |
| 10% least volatile stocks in US Market | 3.2% |
Stable Share Price: Insufficient data to determine HYDI's volatility over the past 3 months.
Volatility Over Time: Insufficient data to determine HYDI's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1980 | n/a | Peter Von Dyck | https://www.hydromer.com |
Hydromer, Inc. invents, develops, patents, licenses, manufactures, and sells hydrophilic polymer-based products and services in the United States and internationally. The company operates in two segments, Polymer Research and Medical Products. It offers medical coatings and services; medical hydrogel; cosmetic intermediaries; and anti-fog/anti-frost condensation control coating products.
Hydromer Fundamentals Summary
| HYDI fundamental statistics | |
|---|---|
| Market Cap | US$1.53m |
| Earnings (TTM) | US$60.91k |
| Revenue (TTM) | US$5.63m |
0.0x
P/E Ratio0.0x
P/S RatioIs HYDI overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| HYDI income statement (TTM) | |
|---|---|
| Revenue | US$5.63m |
| Cost of Revenue | US$1.50m |
| Gross Profit | US$4.13m |
| Other Expenses | US$4.07m |
| Earnings | US$60.91k |
Last Reported Earnings
Jun 30, 2018
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did HYDI perform over the long term?
See historical performance and comparisonDividends
78.1%
Current Dividend Yieldn/a
Payout RatioValuation
Is HYDI undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
2/6Valuation Score 2/6
Price-To-Book vs Peers
Price-To-Book vs Industry
Price-To-Book vs Fair Ratio
Below Fair Value
Significantly Below Fair Value
PEG Ratio
Key Valuation Metric
Which metric is best to use when looking at relative valuation for HYDI?
Other financial metrics that can be useful for relative valuation.
| What is HYDI's n/a Ratio? | |
|---|---|
| n/a Ratio | 0x |
| n/a | n/a |
| Market Cap | US$1.53m |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | n/a |
| Enterprise Value/EBITDA | n/a |
| PEG Ratio | n/a |
Price to Book Ratio vs Peers
How does HYDI's PB Ratio compare to its peers?
| HYDI PB Ratio vs Peers |
|---|
| Company | PB | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 1.5x | ||
NMGX Nano Magic Holdings | 1.6x | n/a | US$2.6m |
ABLT American Biltrite | 0.2x | n/a | US$4.2m |
NNUP Nocopi Technologies | 3x | n/a | US$9.8m |
BON Bon Natural Life | 0.9x | n/a | US$22.9m |
HYDI Hydromer | n/a | n/a | US$1.5m |
Price-To-Book vs Peers: Insufficient data to calculate HYDI's Price-To-Book Ratio vs. peers for valuation analysis.
Price to Earnings Ratio vs Industry
How does HYDI's PE Ratio compare vs other companies in the US Chemicals Industry?
Price-To-Book vs Industry: Insufficient data to calculate HYDI's Price-To-Book Ratio vs. industry for valuation analysis.
Price to Book Ratio vs Fair Ratio
What is HYDI's PB Ratio compared to its Fair PB Ratio? This is the expected PB Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PB Ratio | n/a |
| Fair PB Ratio | n/a |
Price-To-Book vs Fair Ratio: Insufficient data to calculate HYDI's Price-To-Book Fair Ratio for valuation analysis.
Share Price vs Fair Value
What is the Fair Price of HYDI when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: HYDI ($0.32) is trading below our estimate of fair value ($5.63)
Significantly Below Fair Value: HYDI is trading below fair value by more than 20%.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate HYDI's PEG Ratio to determine if it is good value.
Discover undervalued companies
Future Growth
How is Hydromer forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Future Growth Score
0/6Future Growth Score 0/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Future ROE
8.4%
Forecasted Materials industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Hydromer has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Discover growth companies
- Take a look at our analysis of HYDI’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
- While we do not consider unaudited financials to be a reliable enough to include in our analysis, you can access them on the OTC Markets Website. If you are looking for more of a qualitative research into the company, you can access Hydromer's filings and announcements here.
Past Performance
How has Hydromer performed over the past 5 years?
Past Performance Score
0/6Past Performance Score 0/6
Quality Earnings
Growing Profit Margin
Earnings Trend
Accelerating Growth
Earnings vs Industry
High ROE
8.2%
Historical Materials annual earnings growth
In this section we usually display a company’s past earnings and revenues to help investors visualise the trend through time. We also gauge the company’s performance by benchmarking its returns and growth to its industry peers and the wider market. However, Hydromer has not provided sufficient past data to assess its track record.
This is quite a rare situation as 97% of companies covered by Simply Wall St do have historical data.
Discover strong past performing companies
- When a company lacks a financial track record, its management’s track record becomes important. Corporate governance also plays an important role in a young business as board members are seen as highly-experienced leaders to help steer the company into the future. Take a look at Hydromer's management and board experience and expertise to assess their ability to deliver on their strategic promises.
- While we do not consider unaudited financials to be a reliable enough to include in our analysis, you can access them on the OTC Markets Website. If you are looking for more of a qualitative research into the company, you can access Hydromer's filings and announcements here.
Financial Health
How is Hydromer's financial position?
Financial Health Score
0/6Financial Health Score 0/6
Short Term Liabilities
Long Term Liabilities
Debt Level
Reducing Debt
Debt Coverage
Interest Coverage
In this section we usually analyse Hydromer's finance health to determine how well-positioned it is against times of financial distress, in particular, its ability to manage its cash and debt levels. Hydromer has not provided adequate balance sheet data, its financial health cannot be properly assessed as it.
This is quite a rare situation as 97% of companies covered by Simply Wall St do have financial information.
Discover healthy companies
- Take a look at our analysis of HYDI’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
- Investors tend to look at the financial health of a company this size in order to assess the sustainability of its current operations. While we do not consider unaudited financials to be a reliable enough to include in our analysis, you can access them on the OTC Markets Website.
- Financial health is measured at one point in time, so the latest financial report is the best representation of the company’s current financial status. Check when Hydromer's financial data was last updated here.
Dividend
What is Hydromer current dividend yield, its reliability and sustainability?
Dividend Score
2/6Dividend Score 2/6
Notable Dividend
High Dividend
Stable Dividend
Growing Dividend
Earnings Coverage
Future Dividend Coverage
78.13%
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: HYDI's dividend (78.13%) is higher than the bottom 25% of dividend payers in the US market (1.6%).
High Dividend: HYDI's dividend (78.13%) is in the top 25% of dividend payers in the US market (4.3%)
Stability and Growth of Payments
Stable Dividend: Whilst dividend payments have been stable, HYDI has been paying a dividend for less than 10 years.
Growing Dividend: HYDI has only been paying a dividend for 4 years, and since then payments have not increased.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Insufficient data to calculate cash payout ratio to determine if its dividend payments are covered by cash flows.
Discover strong dividend paying companies
Management
How experienced are the management team and are they aligned to shareholders interests?
12.4yrs
Average management tenure
CEO
Peter Von Dyck
3.75yrs
Tenure
Mr. Peter M. von Dyck has been Chief Executive Officer and President of Hydromer, Inc. since September 14, 2018. Mr. von Dyck re-joined Hydromer, Inc. as the Chief Strategy and Business Development Officer...
Leadership Team
Experienced Management: HYDI's management team is seasoned and experienced (12.4 years average tenure).
Board Members
Experienced Board: HYDI's board of directors are seasoned and experienced ( 28.7 years average tenure).
Ownership
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Company Information
Hydromer, Inc.'s employee growth, exchange listings and data sources
Key Information
- Name: Hydromer, Inc.
- Ticker: HYDI
- Exchange: OTCPK
- Founded: 1980
- Industry: Specialty Chemicals
- Sector: Materials
- Implied Market Cap: US$1.527m
- Shares outstanding: 4.77m
- Website: https://www.hydromer.com
Number of Employees
Location
- Hydromer, Inc.
- 35 Industrial Parkway
- Branchburg
- New Jersey
- 08876-3424
- United States
Listings
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2022/06/30 00:00 |
| End of Day Share Price | 2022/06/28 00:00 |
| Earnings | 2018/06/30 |
| Annual Earnings | 2018/06/30 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.